INTRODUCTION
Glioblastoma (GBM) is the most common and aggressive primary brain tumor. Survival in patients receiving the current standard of care is less than a year after diagnosis (1) . A major factor contributing to treatment failure is the ability of tumor cells to infiltrate normal brain regions (2) , extending several centimeters from the tumor bulk edge. Infiltration compromises the ability to achieve complete surgical resection of the tumor, thereby contributing to high recurrence rates, and limitations in the ability to accurately image infiltration reduce the accuracy of target volume delineation for radiotherapy planning (3) . It is crucial to develop imaging modalities that enable better tumor delineation; particularly when considering marginal regions with low tumor cell density.
Despite providing rich insights into tumor characteristics, conventional clinical MRI methods such as contrast-agent enhanced T1 (cT1), T2 weighted (T2), diffusion weighted (DW) or apparent diffusion coefficient maps (ADC), fail to characterize regions of low density tumor cell infiltration. cT1 images allow delineation of strongly enhancing regions corresponding to solid tumor with pathologic neovascularization(4), often surrounding a non-enhancing necrotic core. T2 imaging commonly reveals extensive regions of abnormality surrounding the cT1 enhancing lesion. While these regions are associated with edema, several biopsy studies have demonstrated the presence of infiltrating tumor cells within them (5) , with the extent of the hyper-intensity region being inversely correlated with survival (6) . Evaluating progression of T2 to cT1 abnormalities (7) suggests that high T2 signal regions could represent an earlier stage of tumor development. However, beyond the cT1 enhancement region, there is currently no reliable method for probing the extent and density of tumor cell infiltration. Accurate delineation is often compromised by MRI sensitivity limitations related to the fact that marginal tumor cell density is much lower than healthy tissue cellular density.
Several approaches for probing regions of low tumor cell density are currently under investigation. Infiltration of white matter tracts has been extensively characterized by DTI, with fractional anisotropy properties being related to infiltration patterns (8) . MR spectroscopy focusing on increased choline peaks (9) has probed the hyper-metabolic behavior of tumor cells in the vicinity of the cT1 enhancement region. Perfusion measurements in the same region tend to show increased values due to early angiogenesis (10) . Despite some promising results, most of these approaches suffer from sensitivity limitations restricting their use to regions of higher tumor cell density, typically adjacent to the cT1 abnormal region. However, theoretical invasion models accounting for MRI sensitivity suggest that infiltration may often extend beyond abnormal T2 regions (11) .
Distant from the cT1 enhancement region, invading tumor cells often progress along blood vessels and in the absence of angiogenesis, co-option (12) tends to be the predominant mechanism by which they access blood supply. Published data indicate that even individual cells can disrupt blood-brain barrier (BBB) integrity (13) , thus providing an opportunity to detect tumor infiltration at its earliest stages. Perfusion MRI measurements performed either with the use of contrast agents or by arterial spin labeling (ASL) (14) could allow probing of such effects. Perfusion MRI is already used to improve GBM delineation and facilitate clinical decision making (15) . Contrast-enhanced techniques such as dynamic susceptibility contrast (DSC) and dynamic contrast enhancement (DCE) are widely used in brain tumor imaging (16) , but their relatively low signal to noise ratio (SNR) in infiltrated healthy tissue regions makes subtle perfusion perturbation studies challenging. ASL is non-invasive and has been shown to provide similar results to DSC in brain tumor studies, with fewer susceptibility artefacts (14) . If sufficient SNR could be achieved, this technique, which uses blood water as a marker of perfusion, could be more sensitive to subtle perfusion perturbations in the infiltration zone than other methods, making it a suitable candidate for probing infiltration away from the cT1 enhancement region.
Robustly assessing the ability of MRI protocols to probe tumor infiltration is another important challenge. Clinical studies using stereotactic biopsy techniques are limited to measurements within regions of T2 abnormality, relying on MRI for accurate sampling and typically suffering from low precision (17) . Preclinical studies provide an opportunity for more quantitative histopathologic MRI assessment; however, most studies to date have used qualitative approaches, probably due to difficulties with MRI/histology registration (18) .
Often, histological slices are not cut in the MRI plane and the enormous difference in slice thickness compared with MRI is ignored (histology~20 m, MRI~1000 m). The development of new methods for quantitative histopathologic assessment of MRI modalities is crucial in order to analyse infiltrative glioblastoma models where heterogeneous tumor distributions can vary considerably within the MRI slice thickness.
This study aims to quantitatively and qualitatively analyze the correlation between perfusion MRI signal and tumor cell density at the tumour margins, to assess whether local perfusion perturbation could provide a useful biomarker of glioblastoma cell infiltration in and beyond the peritumoral edema region.
Materials and Methods

Tumor model and experimental design
Experiments were performed on CD1 nude mice (Charles River Laboratories), in accordance with the local ethical review panel (19) . Mice (20-25 g ) were acclimatized at least one week prior to any experimental procedure. G7 human glioblastoma cells were cultured in stem-like conditions (Advanced DMEM:F12, containing 20M EGF/FGF, 1% B27, 0.5% N2, heparin, 1% L-Glut) on Matrigel coated plates. The animals were intracranially injected with G7 cells (10 5 cells per mouse) into the sub-ventricular zone using stereotactic equipment (20) . Study outcomes are reported following the ARRIVE guidelines (21) .
Ten animals were scanned 9 and 12 weeks after GBM cell injection. Following MRI, animals were sacrificed and brains were freeze-fixed to minimize macroscopic tissue deformation (22) . MRI assessment was performed using 3D datasets of registered MRI with Human Leukocyte Antigen density maps achieved by averaging multiple histological slices evenly distributed in the MRI plane.
Four additional animals were scanned at weeks 12 and 15 to allow the formation of a necrotic core. Following MRI, the animals were sacrificed and brains were paraffin embedded to minimize microscopic deformation of cells to allow high-resolution histology analysis.
MRI set up and acquisition
MRI experiments were performed on a Bruker Biospec Avance 7T imaging system with a 30 cm horizontal bore (Bruker, Ettlingen, Germany). Homogeneous radiofrequency excitation was achieved using a birdcage volume resonator (diameter=72 mm, length=110 mm) and an actively decoupled 4-channel phased array receive-only head surface coil was used for signal detection (Rapid Biomedical, Wurzburg, Germany). The system was equipped with shielded magnetic field gradients producing up to 400 mT m -1 .
The animals were anaesthetized using 5% isoflurane and a 30:70 O2/N2O ratio before being 
Histology protocols
Freeze-fixation
Following MRI, anaesthetized mice received an intravenous injection of 0.1 ml 7.5 mg ml 
Paraffin embedding
Mice were sacrificed and brains dissected, cut in half through tumor injection site, formalinfixed, paraffin-embedded and sectioned (4 µm). Sections were stained for hematoxylin and eosin (H&E), Ki67, or incubated with 1:500 dilution HLA antibody (abcam ab70328) and visualised using DAB staining (Dako EnVision + System HRP (DAB) K4007) followed by counterstaining and mounting. Sections were imaged using a Hamamatsu Nanozoomer Slide scanner with Leica SlidePath imaging Software (J.B. 8 years experience) or tiling at x10 on a Zeiss Axio microscope. Figure 1 summarizes the protocol for the production of 3D datasets used for MRI assessment.
Image and data analysis
The most critical steps are highlighted in SuppFig1. Data were processed using Matlab R2015a (MathWorks Ltd., U.K.) code developed in-house.
*** Fig were achieved by subtracting T1 acquisitions before and after Gd injection, and normalizing by T1 data acquired before injection, (MpostGd -MpreGd ) / MpreGd. ADC maps were calculated by fitting the data to the mono-exponential Stejkal-Tanner equation. All data were resized to T2 resolution (176×176) and a mask was applied to null extra-brain regions.
Histology
Histology slice images exported from fluorescence microscopy were registered, resized to MRI data and normalized using the RGB histogram method. Three to five slices (inter-slice distance~0.3 mm) distributed across the MRI slice were averaged to produce tumor cell density maps (TCD), where signal intensity is proportional to the intra-voxel concentration of tumor cell cytoplasm. MRI-TCD registration was performed using an affine intensity-based scheme (mutual information method).
Image segmentation
Tumor-related abnormal regions of interest (ROI) probed by each imaging modality were manually drawn by H.F.I.A. and A.V. (3 and 5 years experience respectively) in the region where the TCD map was produced. PW segmentation was facilitated by comparison with healthy mice PW images (SuppFig.2). MRI ROI delineation was performed without prior knowledge of the histology data, to avoid selection bias. Care was taken not to include noninvasion related enhancement (e.g. ventricle compression). Animals that did not exhibit tumor growth (n=1) were removed from the study while animals with necrotic lesions were not considered for voxel-to-voxel comparison with TCD maps (n=2). Histology ROIs were selected on the basis of HLA stain intensity on TCD maps. To minimise HLA staining artefacts, manual selection was favored to a user-independent intensity-based selection.
Clustering separating high and low tumor density regions within TCD ROIs (A.V. ROI selection) was performed using a gaussian mixture model (26) .
Statistical analysis
TCD ROIs were considered as the "ground truth" for evaluating MRI ROIs. Interobserver reproducibility was quantified using the coefficient of variation (CV), calculated for each lesion by 100×standard deviation/mean, and averaged for each imaging modality. Sensitivity, specificity, accuracy and Dice similarity indices (27, 28) were calculated for each animal and imaging modality. Two tailed student t-test was used for comparisons between MRI tumor regions and histology tumor region. All values are reported as mean ± standard deviation.
Box plots show the mean (black line), median (blue line), 25 th /75 th percentiles (box) and extreme points (whiskers) not considered outliers (within 1.5 times the interquartile range).
Raw data (red dots) are jittered along x. Statistical significance flags: * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001 and NS not statistically significant. contrast enhancement in the brain region were identified at week 12 (e.g. Figure 2C (iii)) and necrotic cores were either very small or invisible. Note that at these earlier time points, T2
RESULTS
A marginal infiltration model
abnormalities appeared more homogeneous and were of similar volume amongst animals 
PW detects more extensive regions of tumor infiltration than conventional MRI
Representative images obtained at weeks 9 and 12 during the longitudinal MRI study are shown in Figure 3A Considering a Gaussian infiltration front (SuppFig.5), the resulting ROI error was estimated at about 10% for the smaller lesions of this work (week 9) and below 1% for medium and large lesions (week 12). Note that this error is small compared to the T2/PW abnormal volume ratio (~60% on week 9 and ~75% on week 12). However, PW was associated with significantly higher sensitivity than other techniques ( Figure 4C ). Conversely, relaxation and diffusion based imaging showed higher specificity than perfusion ( Figure 4D ). This reflects firstly the fact that standard MRI protocols under-evaluate tumor volume and secondly that, while average PW ROI volume (15±3 mm 3 ) was similar to the average TCD ROI volume (16±2 mm 3 ), in three cases PW ROI volumes were found to be greater than TCD ones (by 13%, 8% and 3%).
A relationship between perfusion and invasion in tumor margin regions
Histological analysis was performed to better characterize the relationship between perfusion and tumor cell infiltration. Figure 5A shows a comparison between histological slices probing the perfusion/delivery of FITC-dextran 70kDa and slices from the same animal stained for HLA, in the same region as the MRI images shown in Figure 3A -B. As expected, there is a strong relationship between PW imaging and FITC-dextran staining, with regions of hypoperfusion clearly demarcated by both techniques. Regions of increased tumor cell density exhibited reduced perfusion in both PW and dextran assays; this was also highlighted by the similarity test results comparing TCD ROI with PW ROI (Figure 4A-B) .
This relationship between perfusion and infiltration was stronger in marginal regions of lower tumor cell density. This is highlighted by the dataset from one mouse that developed two distinct tumor lesions ( Figure 5B ): a high density lesion (near the tumor cell injection point) surrounding a small necrotic core (white spots on T2 and ADC; black spots on HLA) and a more homogeneous, low tumor density lesion that appeared later in tumor development. The physical connection between the two lesions, occurring at the back of the brain, is indicated by the red arrows on the T2 images shown in Figure 5B (ii). While both PW and dextran images show a reduction in perfusion in the newly infiltrated lower region, the relation between dextran delivery and invasion is less clear around the necrotic core of the main lesion.
Histological analysis of formalin-fixed tissue allows better understanding of the cellular mechanisms underlying the relationship between marginal tumor infiltration and perfusion. 
Perfusion variation as a marker of tumor cell infiltration
The high values of the segmentation evaluation indices (Figure 4 ) indicate good agreement between MRI and histology datasets, enabling voxel-to-voxel comparison between MRI modalities and TCD maps to be undertaken. PW and TCD images for each animal ( Figure   6A ) were used to produce scatter plots of perfusion against tumor cell density ( Figure 6B ).
Tumor positive voxels on TCD maps that corresponded to manually defined ROI on PW images are highlighted (red points). At the interface between healthy brain and tumor infiltration regions, voxels of extremely low tumor cell density exhibit similar PW values to voxels that are outside the tumor infiltration regions. As suggested by the histology data analysis ( Figure 5 ), perfusion was generally high in low TCD value voxels, and decreased with increasing TCD. This indicated that the voxel-to-voxel approach could be applied to further characterize the relationship between perfusion and invasion at the tumor margins.
This was achieved by comparing high TCD 'tumor core' regions, typically situated around the G7 cell injection point, with low TCD 'tumor margin' regions. To separate these regions, clustering analysis was performed on the tumor positive regions of the TCD maps ( Figure   6A ). By focusing on the tumor region and plotting TCD against PW intensity for each voxel ( Figure 6C ), we generated a semi-quantitative representation of the relationship between tumor burden, as quantified by TDC, and local perfusion. On this graph, marginal voxels (green) exhibit significantly lower average TCD values than core voxels (pink). Importantly, these marginal voxels exhibit significantly higher perfusion values than core voxels ( Figure   6D ). The relation between perfusion and invasion at the margins was quantified by applying separate linear regression fits to the 'core' and the 'margin' voxel data sets ( Figure 6C 
DISCUSSION
This study has demonstrated the existence of an MRI-detectable relationship between tumor cell infiltration and local perfusion in tumor margin regions of an orthotopic glioblastoma model that recapitulates imaging and histopathological features of the human disease. To achieve this, we interrogated our in vivo model, which exhibits infiltrative tumor margins, using a high SNR ASL sequence and a novel MRI validation approach based on the use of multiple histology slices in the MRI plane.
Great care was taken in confirming the clinical relevance of the G7 marginal tumor infiltration model. Firstly, this highly infiltrative model exhibits sizeable regions of low tumor cell density that are not probed by cT1 and which extend into and beyond the regions of abnormal T2 signal. In addition, the relatively slow rate of progression of the G7 model enables considerable cell infiltration to take place, recapitulating the clinical scenario where edema/infiltration T2 lesions are systematically larger than cT1 lesions. By contrast, frequently reported GBM models, where tumor cells poorly infiltrate the depth of the brain tissue, exhibit a sharp transition between tumor bulk and healthy brain regions, resulting in similar sized T2 and cT1 lesions (18) . Without infiltration, tumor growth resembles that of cells injected in avascular spaces, where the lack of host blood vessels is associated with angiogenesis at very early stages in tumor development (29) . As a consequence, these poorly infiltrative models tend not to reproduce the clinically observed difference between cT1 and T2 growth patterns (30) .
Reproducing a realistic marginal invasion microenvironment is another important challenge. high SNR perfusion images the perfusion gradient could be used as a direct marker of tumor cell infiltration into the healthy tissue, lower SNR perfusion images could still potentially be used to produce tumor infiltration probability maps. It is also crucial to consider the impact of alternative, clinically relevant causes of local perfusion perturbation, such as radiation therapy and surgery, which may limit the applicability of this technique to pre-therapy planning. However, the ability of this approach to improve tumor delineation at the initial treatment planning stage would be of enormous value, and might lead to better responses to first line surgery and radiation therapy.
This study was, by necessity, subject to certain limitations which we have sought to address, both in its design and also through consideration of its potential for clinical translation. First, our analysis used a relatively small number of mice, mainly imposed by the time consuming data acquisition and histology processing protocols. This was counterbalanced by the introduction of a quantitative histopathologic assessment method which enabled collection of high quality data from each mouse, and our main findings exhibited robust statistical significance. Another limitation relates to differences between tumor and vessel growth between human gliomas and the G7 model in which tumors grow in the brains of immunodeficient mice. We contend that immune status is unlikely to have a significant effect on the analysis of the relation between local perfusion and tumor burden proposed here. In fact, the tumor-related perfusion drop was related to infiltration through the biomechanical effect of vascular co-option and/or edema, which are clinically relevant mechanisms. To minimize intracranial pressure and vascular compression effects, tumor size was generally limited to less than 10% of total brain volume. This also increased the relevance of evaluation tests requiring significant difference between tumor volume and brain volume (27) . 
